Advertisement
CorrigendumNeuroscience Free access | 10.1172/JCI25437C1
Find articles by Obata, K. in: JCI | PubMed | Google Scholar
Find articles by Katsura, H. in: JCI | PubMed | Google Scholar
Find articles by Mizushima, T. in: JCI | PubMed | Google Scholar
Find articles by Yamanaka, H. in: JCI | PubMed | Google Scholar
Find articles by Kobayashi, K. in: JCI | PubMed | Google Scholar
Find articles by Dai, Y. in: JCI | PubMed | Google Scholar
Find articles by Fukuoka, T. in: JCI | PubMed | Google Scholar
Find articles by Tokunaga, A. in: JCI | PubMed | Google Scholar
Find articles by Tominaga, M. in: JCI | PubMed | Google Scholar
Find articles by Noguchi, K. in: JCI | PubMed | Google Scholar
Published January 4, 2010 - More info
Cold hyperalgesia is a well-documented symptom of inflammatory and neuropathic pain; however, the underlying mechanisms of this enhanced sensitivity to cold are poorly understood. A subset of transient receptor potential (TRP) channels mediates thermosensation and is expressed in sensory tissues, such as nociceptors and skin. Here we report that the pharmacological blockade of TRPA1 in primary sensory neurons reversed cold hyperalgesia caused by inflammation and nerve injury. Inflammation and nerve injury increased TRPA1, but not TRPM8, expression in tyrosine kinase A–expressing dorsal root ganglion (DRG) neurons. Intrathecal administration of anti–nerve growth factor (anti-NGF), p38 MAPK inhibitor, or TRPA1 antisense oligodeoxynucleotide decreased the induction of TRPA1 and suppressed inflammation- and nerve injury–induced cold hyperalgesia. Conversely, intrathecal injection of NGF, but not glial cell line–derived neurotrophic factor, increased TRPA1 in DRG neurons through the p38 MAPK pathway. Together, these results demonstrate that an NGF-induced TRPA1 increase in sensory neurons via p38 activation is necessary for cold hyperalgesia. Thus, blocking TRPA1 in sensory neurons might provide a fruitful strategy for treating cold hyperalgesia caused by inflammation and nerve damage.
Koichi Obata, Hirokazu Katsura, Toshiyuki Mizushima, Hiroki Yamanaka, Kimiko Kobayashi, Yi Dai, Tetsuo Fukuoka, Atsushi Tokunaga, Makoto Tominaga, Koichi Noguchi
Original citation: J. Clin. Invest.115:2393–2401 (2005). doi:10.1172/JCI25437.
Citation for this corrigendum: J. Clin. Invest.120:394 (2010). do:10.1172/JCI25437C1.
During the preparation of the manuscript, the number of samples used for the quantification of RT-PCR depicted in Figure 2E was stated incorrectly. The corrected legend appears below.
(E) mRNA expression of TRPA1 and TRPM8 in the DRG after inflammation, as detected by RT-PCR. Quantification of RT-PCR data is shown at right. Data represent mean ± SD; n = 3 per group. *P < 0.05 compared with the naive control.
The authors regret the error.